Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Annual Report

Biofil Chemicals & Pharmaceuticals Annual Report

Biofil Chemicals and Pharmaceuticals Limited has submitted its Integrated Annual Report for FY 2025-26. The 41st Annual General Meeting is scheduled for September 23, 2026.

Source

BSE filing, NSE: BIOFILCHEM. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Biofil Chemicals & Pharmaceuticals Ltd: key numbers

Share price
₹29.26
Market cap
₹47.62 Cr
Revenue (annual)
₹28.40 Cr
Net profit (annual)
₹2.79 Cr
P/E (TTM)
98.4×Sector 46.1×
Promoter holding
46.79%+0.00% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Biofil Chemicals & Pharmaceuticals Ltd

All →

Other annual report announcements

All →